Journal of Generic Medicines
Journal of Generic Medicines is a journal indexed in SJR in Pharmaceutical Science with an H index of 14. It has a best quartile of Q4. It is published in English.
Metrics
Scimago and CountryOfPapers database fields
SJR Impact
—
H-index
14
Docs (year)
0
Docs 3y
30
Total refs
0
Cites 3y
5
Citable 3y
24
Cites/Doc 2y
21
Ref/Doc
0.0
Immediate OA
—
Embargoed OA
NPD
Non OA / Submission
—
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Book Review
View moreWould the Trans-Pacific Partnership Agreement undermine Japan's efforts to control health care expenditures?
View moreEU Case Reports
View moreEditorial
View moreEditorial
View moreDon't kill this goose: Government policy should facilitate India to become pharmacy of the world
View moreDoes the patent office really believe delay occurs before it actually occurs? The effect of Wyeth et al v. Dudas on patent term adjustments
View moreDeveloping a legislative pathway for biosimilars in the United States
View moreData protection: The new IP Frontier - An overview of existing laws and regulations
View moreCreating a workable biogenerics pathway for patients
View moreCarved out indications and patents in Australia: The story continues
View moreBranding of new and generic/biosimilar products: New concepts and methods (in-depth qualitative study)
View moreBook Reviews
View moreA buyer's guide to generic pharmaceutical acquisitions
View moreBiological generics: A business case
View moreAttention API suppliers: Quality agreements are here to stay
View moreAssessment of generic drug discount programs offered by large chain pharmacies in the United States
View moreAssessment methodology for performing regulatory due diligence based on a quantitative approach
View moreAll costs, no benefits: How the US-Jordan free trade agreement affects access to medicines
View moreAbbott v. Sandoz: Judicial clarity on the interpretation of product-by-process claims
View moreAbbott v. Sandoz: If at first you don't succeed, try, try again
View moreA triumph for generic medicines and the right to health in Africa Patricia Asero Ochieng & Ors. v. Attorney General (Petition No. 409 of 2009, Judgment of the Kenyan High Court, 20 April 2012)
View moreA survey assessing knowledge and perception of prescribers towards generic medicines in Hospital Seberang Jaya
View moreA review of recent developments at the multilateral level with respect to intellectual property and the pharmaceutical industry
View more